Bilaketaren emaitzak - Lisa Bodei

Findu emaitzak
  1. 1
    Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes

    Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes nork F. Edward Boas, Lisa Bodei, Constantinos T. Sofocleous

    Argitaratua 2017
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Is the Vision of Radioligand Therapy for Prostate Cancer Becoming a Reality? An Overview of the Phase III VISION Trial and Its Importance for the Future of Theranostics

    Is the Vision of Radioligand Therapy for Prostate Cancer Becoming a Reality? An Overview of the Phase III VISION Trial and Its Importance for the Future of Theranostics nork Kambiz Rahbar, Lisa Bodei, Michael J. Morris

    Argitaratua 2019
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Current Concepts in <sup>68</sup>Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular Strategies

    Current Concepts in <sup>68</sup>Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular Strategies nork Lisa Bodei, Valentina Ambrosini, Ken Herrmann, Irvin M. Modlin

    Argitaratua 2017
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Somatostatin Receptor 2–Targeting Compounds

    Somatostatin Receptor 2–Targeting Compounds nork Daan A. Smit Duijzentkunst, Dik J. Kwekkeboom, Lisa Bodei

    Argitaratua 2017
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  5. 5
    The Status of Neuroendocrine Tumor Imaging: From Darkness to Light?

    The Status of Neuroendocrine Tumor Imaging: From Darkness to Light? nork Lisa Bodei, Anders Sundin, Mark Kidd, Vikas Prasad, Irvin M. Modlin

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Radiopharmaceutical therapy in cancer: clinical advances and challenges

    Radiopharmaceutical therapy in cancer: clinical advances and challenges nork George Sgouros, Lisa Bodei, Michael R. McDevitt, Jessie R. Nedrow

    Argitaratua 2020
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Radiotheranostics in oncology: current challenges and emerging opportunities

    Radiotheranostics in oncology: current challenges and emerging opportunities nork Lisa Bodei, Ken Herrmann, Heiko Schöder, Andrew M. Scott, Jason S. Lewis

    Argitaratua 2022
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  8. 8
    A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by proton pump inhibitors

    A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by proton pump inhibitors nork Irvin M. Modlin, Harry R. Aslanian, Lisa Bodei, Ignat Drozdov, Mark Kidd

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Neuroendocrine Tumor Biomarkers: Current Status and Perspectives

    Neuroendocrine Tumor Biomarkers: Current Status and Perspectives nork Irvin M. Modlin, Kjell Öberg, Andrew Taylor, Ignat Drozdov, Lisa Bodei, Mark Kidd

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide

    Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide nork Serafino Ricci, Andrea Antonuzzo, Luca Galli, M Ferdeghini, Lisa Bodei, Cinzia Orlandini, Pierfranco Conté

    Argitaratua 2000
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Circulating Transcript Analysis (NETest) in GEP-NETs Treated With Somatostatin Analogs Defines Therapy

    Circulating Transcript Analysis (NETest) in GEP-NETs Treated With Somatostatin Analogs Defines Therapy nork Jarosław B. Ćwikła, Lisa Bodei, Agnieszka Kolasińska-Ćwikła, A Sankowski, Irvin M. Modlin, Mark Kidd

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray”

    Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray” nork Boudewijn Brans, Lisa Bodei, Francesco Giammarile, O. Lindén, Markus Luster, Wim J.G. Oyen, Jan Tennvall

    Argitaratua 2007
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Yttrium-labelled peptides for therapy of NET

    Yttrium-labelled peptides for therapy of NET nork Lisa Bodei, Marta Cremonesi, Chiara Maria Grana, Marco Chinol, Silvia M. Baio, Stefano Severi, Giovanni Paganelli

    Argitaratua 2012
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors

    Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors nork Lisa Bodei, Marta Cremonesi, Mark Kidd, Chiara Maria Grana, Stefano Severi, Irvin M. Modlin, Giovanni Paganelli

    Argitaratua 2014
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  15. 15
    The NETest

    The NETest nork Irvin M. Modlin, Mark Kidd, Anna Malczewska, Ignat Drozdov, Lisa Bodei, Somer Matar, Kyung-Min Chung

    Argitaratua 2018
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Targeted therapy in nuclear medicine—current status and future prospects

    Targeted therapy in nuclear medicine—current status and future prospects nork Wim J.G. Oyen, Lisa Bodei, Francesco Giammarile, Helmut R. Maëcke, Jan Tennvall, Markus Luster, Boudewijn Brans

    Argitaratua 2007
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  17. 17
    The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors

    The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors nork Anna Malczewska, Beata Kos‐Kudła, Mark Kidd, Ignat Drozdov, Lisa Bodei, Somer Matar, Kjell Öberg, Irvin M. Modlin

    Argitaratua 2019
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy

    Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy nork Lisa Bodei, Heiko Schöder, Richard P. Baum, Ken Herrmann, Jonathan Strosberg, Martyn Caplin, Kjell Öberg, Irvin M. Modlin

    Argitaratua 2020
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Neuroendocrine Neoplasms of the Small Bowel and Pancreas

    Neuroendocrine Neoplasms of the Small Bowel and Pancreas nork Ashley Kieran Clift, Mark Kidd, Lisa Bodei, Christos Toumpanakis, Richard P. Baum, Kjell Öberg, Irvin M. Modlin, Andrea Frilling

    Argitaratua 2019
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  20. 20
    GEP–NETs UPDATE: Radionuclide therapy in neuroendocrine tumors

    GEP–NETs UPDATE: Radionuclide therapy in neuroendocrine tumors nork Wouter A. van der Zwan, Lisa Bodei, Jan Mueller‐Brand, Wouter W. de Herder, Larry K. Kvols, Dik J. Kwekkeboom

    Argitaratua 2014
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: